These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 18761509)

  • 21. Natural history of human papillomavirus infections, cytologic and histologic abnormalities, and cancer.
    Wheeler CM
    Obstet Gynecol Clin North Am; 2008 Dec; 35(4):519-36; vii. PubMed ID: 19061814
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Women's knowledge about human papillomavirus and their acceptance of HPV vaccine.
    Dursun P; Altuntas B; Kuscu E; Ayhan A
    Aust N Z J Obstet Gynaecol; 2009 Apr; 49(2):202-6. PubMed ID: 19432612
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cost-effectiveness of human papillomavirus vaccination in Belgium: do not forget about cervical cancer screening.
    Thiry N; De Laet C; Hulstaert F; Neyt M; Huybrechts M; Cleemput I
    Int J Technol Assess Health Care; 2009 Apr; 25(2):161-70. PubMed ID: 19366497
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human papillomavirus and cervical cancer in Australasia and Oceania: risk-factors, epidemiology and prevention.
    Garland SM; Brotherton JM; Skinner SR; Pitts M; Saville M; Mola G; Jones RW
    Vaccine; 2008 Aug; 26 Suppl 12():M80-8. PubMed ID: 18945417
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human papillomavirus vaccine policy and delivery in Latin America and the Caribbean.
    Andrus JK; Lewis MJ; Goldie SJ; García PJ; Winkler JL; Ruiz-Matus C; de Quadros CA
    Vaccine; 2008 Aug; 26 Suppl 11():L80-7. PubMed ID: 18945405
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A review of prophylactic human papillomavirus vaccines: recommendations and monitoring in the US.
    Dunne EF; Datta SD; E Markowitz L
    Cancer; 2008 Nov; 113(10 Suppl):2995-3003. PubMed ID: 18980283
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Attitudes toward HPV vaccination among parents of adolescent girls in Mysore, India.
    Madhivanan P; Krupp K; Yashodha MN; Marlow L; Klausner JD; Reingold AL
    Vaccine; 2009 Aug; 27(38):5203-8. PubMed ID: 19596420
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Physicians' experiences with HPV vaccine delivery: evidence from developing country with multiethnic populations.
    Wong LP
    Vaccine; 2009 Mar; 27(10):1622-7. PubMed ID: 19100803
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human papilloma virus vaccination: should it be mandatory?
    Prasai S
    JNMA J Nepal Med Assoc; 2008; 47(171):167-71. PubMed ID: 19079386
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cervical cancer vaccine.
    Nicoletti A
    J Pediatr Adolesc Gynecol; 2006 Dec; 19(6):423-4. PubMed ID: 17174835
    [No Abstract]   [Full Text] [Related]  

  • 31. Sexual behaviour in Ligurian (Northern Italy) adolescents and young people: suggestions for HPV vaccination policies.
    Panatto D; Amicizia D; Lugarini J; Sasso T; Sormani MP; Badolati G; Gasparini R
    Vaccine; 2009 May; 27 Suppl 1():A6-10. PubMed ID: 19480964
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The health and economic impact of cervical cancer screening and human papillomavirus vaccination in kidney transplant recipients.
    Wong G; Howard K; Webster A; Chapman JR; Craig JC
    Transplantation; 2009 Apr; 87(7):1078-91. PubMed ID: 19352131
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mathematical models of cervical cancer prevention in the Asia Pacific region.
    Goldie SJ; Diaz M; Kim SY; Levin CE; Van Minh H; Kim JJ
    Vaccine; 2008 Aug; 26 Suppl 12():M17-29. PubMed ID: 18945411
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potential barriers to HPV vaccine provision among medical practices in an area with high rates of cervical cancer.
    Keating KM; Brewer NT; Gottlieb SL; Liddon N; Ludema C; Smith JS
    J Adolesc Health; 2008 Oct; 43(4 Suppl):S61-7. PubMed ID: 18809147
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Screening and early diagnosis of cervical cancer in a context of HPV vaccination].
    Bergeron C
    Rev Prat; 2010 Feb; 60(2):214-5. PubMed ID: 20225561
    [No Abstract]   [Full Text] [Related]  

  • 36. Prevention of human papillomavirus infections and associated diseases by vaccination: a new hope for global public health.
    Harper DM
    Public Health Genomics; 2009; 12(5-6):319-30. PubMed ID: 19684444
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Singaporean men's knowledge of cervical cancer and human papillomavirus (HPV) and their attitudes towards HPV vaccination.
    Pitts M; Smith A; Croy S; Lyons A; Ryall R; Garland S; Wong ML; Hseon TE
    Vaccine; 2009 May; 27(22):2989-93. PubMed ID: 19428910
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The new human papillomavirus (HPV) vaccine: pros and cons for pediatric and adolescent health.
    Thomas TL
    Pediatr Nurs; 2008; 34(5):429-31. PubMed ID: 19051848
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Politics, parents, and prophylaxis--mandating HPV vaccination in the United States.
    Charo RA
    N Engl J Med; 2007 May; 356(19):1905-8. PubMed ID: 17494922
    [No Abstract]   [Full Text] [Related]  

  • 40. Cost-effectiveness of prophylactic vaccination against human papillomavirus 16/18 for the prevention of cervical cancer: adaptation of an existing cohort model to the situation in the Netherlands.
    Rogoza RM; Westra TA; Ferko N; Tamminga JJ; Drummond MF; Daemen T; Wilschut JC; Postma MJ
    Vaccine; 2009 Jul; 27(35):4776-83. PubMed ID: 19539578
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.